Mathilde Pohin

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Insulin Resistance

Top Venues

The EMBO journal

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, Klara Piletic, Ghada Alsaleh, Ramona Zummach, Julia Hecker, Mathilde Pohin, Nicholas Edward Ilott, Irina Guschina, Sarah Karin Wideman, Errin Johnson, Mariana Borsa, Paula Hahn, Christophe Morriseau, Bruce D Hammock, Henk Simon Schipper, Claire M Edwards, Rudolf Zechner, Britta Siegmund, Carl Weidinger, Nils Helge Schebb, Fiona M Powrie, Anna Katharina Simon
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10. The EMBO journal 42 (6) (2023)
Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, Klara Piletic, Ghada Alsaleh, Ramona Zummach, Julia Hecker, Mathilde Pohin, Nicholas Edward Ilott, Irina Guschina, Sarah Karin Wideman, Errin Johnson, Mariana Borsa, Paula Hahn, Christophe Morriseau, Bruce D Hammock, Henk Simon Schipper, Claire M Edwards, Rudolf Zechner, Britta Siegmund, Carl Weidinger, Nils Helge Schebb, Fiona M Powrie, Anna Katharina Simon
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10. The EMBO journal 42 (6) (2023)
Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, Klara Piletic, Ghada Alsaleh, Ramona Zummach, Julia Hecker, Mathilde Pohin, Nicholas Edward Ilott, Irina Guschina, Sarah Karin Wideman, Errin Johnson, Mariana Borsa, Paula Hahn, Christophe Morriseau, Bruce D Hammock, Henk Simon Schipper, Claire M Edwards, Rudolf Zechner, Britta Siegmund, Carl Weidinger, Nils Helge Schebb, Fiona M Powrie, Anna Katharina Simon
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10. The EMBO journal (2023)
Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, Klara Piletic, Ghada Alsaleh, Ramona Zummach, Julia Hecker, Mathilde Pohin, Nicholas Edward Ilott, Irina Guschina, Sarah Karin Wideman, Errin Johnson, Mariana Borsa, Paula Hahn, Christophe Morriseau, Bruce D Hammock, Henk Simon Schipper, Claire M Edwards, Rudolf Zechner, Britta Siegmund, Carl Weidinger, Nils Helge Schebb, Fiona M Powrie, Anna Katharina Simon
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10. The EMBO journal (2023)
Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, Klara Piletic, Ghada Alsaleh, Ramona Zummach, Julia Hecker, Mathilde Pohin, Nicholas Edward Ilott, Irina Guschina, Sarah Karin Wideman, Errin Johnson, Mariana Borsa, Paula Hahn, Christophe Morriseau, Bruce D Hammock, Henk Simon Schipper, Claire M Edwards, Rudolf Zechner, Britta Siegmund, Carl Weidinger, Nils Helge Schebb, Fiona M Powrie, Anna Katharina Simon
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10. The EMBO journal 42 (6) (2023)
Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, Klara Piletic, Ghada Alsaleh, Ramona Zummach, Julia Hecker, Mathilde Pohin, Nicholas Edward Ilott, Irina Guschina, Sarah Karin Wideman, Errin Johnson, Mariana Borsa, Paula Hahn, Christophe Morriseau, Bruce D Hammock, Henk Simon Schipper, Claire M Edwards, Rudolf Zechner, Britta Siegmund, Carl Weidinger, Nils Helge Schebb, Fiona M Powrie, Anna Katharina Simon
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10. The EMBO journal 42 (6) (2023)
Matthias Friedrich, Mathilde Pohin, Matthew A Jackson, Ilya Korsunsky, Samuel J Bullers, Kevin Christophe Rue-Albrecht, Zoe Christoforidou, Dharshan Sathananthan, Tom Thomas, Rahul Ravindran, Ruchi Tandon, Raphael Sanches Peres, Hannah R Sharpe, Kevin Wei, Gerald F M Watts, Elizabeth H Mann, Alessandra Geremia, Moustafa Attar, null null, null null, Sarah McCuaig, Lloyd Thomas, Elena Collantes, Hans Holm Uhlig, Stephen N Sansom, Alistair Easton, Soumya Raychaudhuri, Simon P L Travis, Fiona M Powrie
IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies. Nature medicine 27 (11) (2021)